COVID-19 | Manjunath advocates use of remdesivir in treatment
[ad_1]
He emphasises that the antiviral drug needs to be administered to COVID-19 sufferers earlier than they flip extraordinarily sick
Cardiologist C.N. Manjunath has favoured the use of antiviral drug remdesivir in the treatment of reasonably sick COVID-19 sufferers.
His advice comes even after a World Health Organisation (WHO) examine indicated that remdesivir appeared to have little or no impact on 28-day mortality or in-hospital course of COVID-19 amongst hospitalised sufferers.
Participating in a digital panel dialogue on Infectious Diseases Control organised by e-Health journal printed by Elets Technomedia not too long ago, Dr. Manjunath, who can be the Director of state-run Sri Jayadeva Institute of Cardiovascular Sciences and Research, mentioned the knowledgeable pulmonologists in the State strongly felt that remdesivir is efficient when it’s given on the “right time to the right patient”.
He described as “quite satisfactory” the expertise of seven famend pulmonologists, who’re additionally half of the State’s Expert Committee on COVID-19 treatment. These pulmonologists deal with lots of of sufferers every day, Dr. Manjunath mentioned.
However, he emphasised that the antiviral drug needs to be given to sufferers earlier than they flip “extremely sick”.
About 300 folks in Jayadeva Institute of Cardiovascular Sciences and Research in Bengaluru too had examined constructive and 30 of them have been very sick. The sufferers have been handled with a mixture of remdesivir and different medication. Fortunately, there was no mortality and all of them recovered.
Also, Dr. Manjunath mentioned the associated fee of the antiviral drug has been decreased since June-July together with different consumables.
Contending that the healthcare situation in the State was progressing positively, Dr. Manjunath mentioned physicians engaged in the treatment of COVID-19 now believe that almost all of the contaminated sufferers will get better as about 90% of the constructive instances had been cured on their very own or by way of easy treatment. According to a examine, Dr. Manjunath mentioned about 8% required oxygen.
He additionally made out a case for paying parallel consideration to non-COVID-19 instances. “We are talking only about COVID-19, but a lot of non-COVID patients too are suffering today,” he mentioned whereas declaring {that a} examine had indicated that a number of folks have been dying resulting from cardiac and renal points.
[ad_2]
